James P. Moriarty

机构：Mayo Clinic, Gloucestershire Hospitals NHS Foundation Trust, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0002-5139-1932

发表论文 148 篇 · 总被引 4052 次 · h-index 36

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 98)
• Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial (2021 · PLoS ONE · 被引 83)
• Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening (2021 · The American Journal of Gastroenterology · 被引 37)
• Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis (2021 · American Journal of Preventive Cardiology · 被引 31)
• Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People (2021 · Mayo Clinic Proceedings · 被引 31)